Shenzhen Hepalink Pharmaceutical Co. Ltd. | Cash Flow
Fiscal year is January-December. All values CNY Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
313,419.70
335,331.40
568,078.00
386,118.20
118,188.80
592
Depreciation, Depletion & Amortization
25,416.70
34,452.00
104,003.10
170,802.90
164,874.10
227
Other Funds
1,132.90
18,305.30
190,559.80
77,733.80
166,106.70
494
Funds from Operations
340,830.10
416,593.60
782,205.50
664,523.40
435,838.20
1,285
Changes in Working Capital
80,544.00
498,051.00
223,389.50
196,396.80
812,693.40
557
Net Operating Cash Flow
421,374.10
914,644.70
1,005,595.00
468,126.70
376,855.20
729
Capital Expenditures
293,975.20
167,622.60
168,848.80
359,536.20
576,130.50
Sale of Fixed Assets & Businesses
88.30
795.00
1,349.40
49,469.00
1,387.10
Purchase/Sale of Investments
113,160.00
2,647,374.60
392,147.60
36,425.20
606,763.60
Net Investing Cash Flow
407,046.90
2,814,213.90
1,767,809.90
346,492.40
1,236,843.50
Cash Dividends Paid - Total
480,120.00
240,060.00
240,060.00
467,700.60
311,800.40
Issuance/Reduction of Debt, Net
73,099.50
231,792.10
1,240,512.10
771,079.70
1,042,360.70
Net Financing Cash Flow
552,086.50
26,573.20
809,892.40
225,645.30
564,453.50
Net Change in Cash
538,205.10
1,924,259.20
58,875.10
360,348.90
1,055,526.50
Free Cash Flow
127,398.90
747,022.10
836,746.30
108,590.50
952,985.80
Deferred Taxes & Investment Tax Credit
555.00
1,004.60
16,321.20
20,838.30
150,451.50
28
Net Assets from Acquisitions
-
-
1,207,093.10
-
-
Other Sources
-
-
-
-
1,094.90
Exchange Rate Effect
445.70
1,883.40
11,197.50
13,069.40
6,281.30
Other Uses
-
11.80
1,069.70
-
56,431.30
About Shenzhen Hepalink Pharmaceutical Co.
View Profile
